ArticleActa pharmaceutica Sinica. B2026

Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model.

Hengyue Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.